Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of 10µg Hepatitis B Vaccine
NCT02152709Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Nov 2008
- Primary completion
- Mar 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Nov 2008; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02152709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152709.